Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis: a systematic review based on evidence
By
- AMS
posted
Apr 06, 2021 11:20 AM
0
Recommend
.
0 comments
0 views
Related Content
New evidence-based resources to guide treatment of plaque psoriasis
- AMS
Added Sep 08, 2021
Blog Entry
A systematic review of evidence based treatments for lichen simplex chronicus
- AMS
Added Mar 06, 2020
Blog Entry
Topical treatment for postinflammatory hyperpigmentation: a systematic review
- AMS
Added Sep 28, 2021
Blog Entry
Systematic literature review of long-term efficacy data for topical psoriasis treatments
- AMS
Added Jun 01, 2021
Blog Entry
Microneedling Plus Topical Pimecrolimus Show Positive Outcomes in Vitiligo Care
- AMS
Added Jan 05, 2022
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic